Last Updated:
11:15 am
Friday, July 4, 2025
TrivarX Ltd. engages in clinical research, product development, and early-stage commercialization of mental health technology. Its product is used to assist in the screening, diagnosing, monitoring and management of depression and other mental health conditions. The company was founded in 1998 and is headquartered in South Melbourne, Australia.
asx-tri
Market Cap
AU$6.20M
Volume
921
Open
0.01
AU$
High
0.01
AU$
Low
0.01
AU$
Shares On Issue
455M
52 Week Low
0.007
AU$
52 Week High
0.045
AU$
Website
www.medibio.com.au
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved